Canton Strategic Holdings (CNTN) Interest Coverage Ratio (2021 - 2025)
Canton Strategic Holdings' (CNTN) quarterly Interest Coverage Ratio came in at 3349.24 in Q4 2025, up 33.43% YoY from 2510.09 in Q4 2024, and down 1443.46% on a QoQ basis from 217.0 in Q3 2025.
Powered by 
Analysis
Canton Strategic Holdings (CNTN) Interest Coverage Ratio (2021 - 2025) Analysis & Trends
Canton Strategic Holdings (CNTN) has 5 years of Interest Coverage Ratio data on file, last reported at 3349.24 in Q4 2025.
- Quarterly Interest Coverage Ratio rose 33.43% year-over-year to 3349.24 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was 2738.64 (down 279.41% YoY) and the FY2025 annual result came in at 3.96, down 225.28% from the prior year.
- Interest Coverage Ratio declined to 3349.24 in Q4 2025, from 217.0 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 242.97 in Q3 2022 to a low of 7150.16 in Q4 2023.
- A 5-year average of 1036.62 and a median of 300.63 in 2025 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio soared 10697.05% — and 2023, when it tumbled 635198.41%.
- Tracing CNTN's Interest Coverage Ratio over 5 years: stood at 0.39 in 2021, then jumped by 385.91% to 1.13 in 2022, then plunged by 635198.41% to 7150.16 in 2023, then gained by 29.63% to 5031.23 in 2024, then surged by 33.43% to 3349.24 in 2025.
- The last three Interest Coverage Ratio figures came in at 3349.24 (Q4 2025), 217.0 (Q3 2025), and 300.46 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Canton Strategic Holdings | 493.37 Mn | 493.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -3,347.13 |
| Sep 30, 2025 | -217.00 |
| Jun 30, 2025 | -231.88 |
| Mar 31, 2025 | -300.63 |
| Dec 31, 2024 | -5,075.81 |
| Sep 30, 2024 | -1,284.67 |
| Jun 30, 2024 | -454.95 |
| Mar 31, 2024 | -499.43 |
| Dec 31, 2023 | -7,150.16 |
| Sep 30, 2023 | -527.77 |
| Jun 30, 2023 | -362.84 |
| Mar 31, 2023 | -442.23 |
| Dec 31, 2022 | 201.74 |
| Mar 31, 2022 | -0.84 |
| Dec 31, 2021 | -0.39 |
| Sep 30, 2021 | -2.29 |
| Jun 30, 2021 | -5.81 |
| Mar 31, 2021 | -9.90 |